Weyant, Kevin B. http://orcid.org/0000-0002-6185-8743
Oloyede, Ayomide
Pal, Sukumar
Liao, Julie
Jesus, Mariela Rivera-De
Jaroentomeechai, Thapakorn
Moeller, Tyler D.
Hoang-Phou, Steven
Gilmore, Sean F.
Singh, Riya
Pan, Daniel C.
Putnam, David
Locher, Christopher
de la Maza, Luis M.
Coleman, Matthew A.
DeLisa, Matthew P. http://orcid.org/0000-0003-3226-1566
Funding for this research was provided by:
National Science Foundation (DGE-1650441)
K.B.W. was also supported by a Cornell Fleming Graduate Scholarship
T.J. was supported by a Royal Thai Government Fellowship and a Cornell Fleming Graduate Scholarship
U.S. Department of Health & Human Services | National Institutes of Health (T32EB023860, R01GM137314, R01GM127578, U19AI144184)
T.D.M. was also supported by a Cornell Fleming Graduate Scholarship
Bill and Melinda Gates Foundation (OPP1217652)
United States Department of Defense | Defense Threat Reduction Agency (HDTRA1-20-10004)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
Article History
Received: 24 August 2021
Accepted: 15 January 2023
First Online: 28 January 2023
Competing interests
: M.P.D. has a financial interest in Gauntlet, Inc., Glycobia, Inc., MacImmune, Inc., SwiftScale, Inc., and UbiquiTX, Inc. M.P.D. and D.P. have a financial interest in Versatope Therapeutics, Inc. M.P.D.’s and D.P.’s interests are reviewed and managed by Cornell University in accordance with their conflict-of-interest policies. M.P.D. has no non-financial competing interests to declare. All other authors declare no competing interests.